INTRODUCTION
============

Wallerian degeneration (WD), the progressive self-destruction of the distal segment of injured axons, is an active process that is tightly controlled at molecular and cellular levels ([@R1]--[@R4]). The current understanding of WD centers on nicotinamide adenine dinucleotide (NAD^+^) and genes regulating NAD^+^ metabolism ([@R5], [@R6]). The expression of "*Wallerian degeneration slow*" \[*Wld^S^*, a chimeric gene containing the NAD^+^ biosynthetic enzyme nicotinamide mononucleotide adenylyltransferase (Nmnat) 1\], overexpression (OE) of Nmnat, and supplement of NAD^+^ or its precursors can all delay WD ([@R5], [@R7]). Consistently, a rapid turnover of the cytoplasmic isoform Nmnat2 is linked to injury-induced NAD^+^ depletion ([@R8]). Last, sterile alpha and TIR motif--containing 1 (Sarm1) may act as a NAD^+^ hydrolase to promote axonal degeneration ([@R9]--[@R12]). However, other than NAD^+^ and the related regulatory mechanisms, the rest of the complex signaling pathways involved in the initiation of WD remain poorly understood.

The endosomal sorting complexes required for transport (ESCRT) machinery plays a vital role in membrane remodeling and is involved in the regulation of a number of important cellular processes such as cellular abscission, viral budding, and the biogenesis of multivesicular bodies (MVBs) ([@R13], [@R14]). The ESCRT machinery consists of four complexes, namely, ESCRT-0, -I, -II, and -III, as well as the ESCRT accessory proteins such as vacuolar protein sorting 4 (Vps4). The ESCRT-III complex recruits Vps4, which catalyzes the dissociation of ESCRT-III components from the endosomal membranes to recycle them as well as Vps4 itself. The repeated assembly-disassembly of the ESCRT-III and the Vps4 complex is required for maintaining the biogenesis and function of MVBs in cells ([@R13], [@R15], [@R16]).

Autophagy is a "self-eating" process of the cell that sequesters misfolded proteins and dysfunctional organelles to autophagosomes (APs) and subsequently delivers them to lysosomes for degradation. The process of AP formation is regulated by a series of evolutionarily conserved autophagy-related (*Atg*) genes. In addition, defects in the fusion of APs and lysosomes are associated with *Vps4* mutants in worm, fly, and human cells ([@R17]--[@R19]), implicating a molecular link between Vps4 and autophagy. Emerging evidence shows that autophagy plays an important role in maintaining the homeostasis in neurons, and mutations in the genes encoding the components of the ESCRT machinery are associated with dysfunctional autophagy in neurodevelopment and chronic neurodegenerative diseases ([@R13], [@R20], [@R21]). In this study, we have identified the ESCRT protein Vps4 as an important novel player in acute neural injury, which is required for maintaining autophagic flux in axons, and its rapid depletion upon injury may underlie the initiation of WD.

RESULTS
=======

Identification of *Vps4* as an anti-degenerative gene in WD using an in vivo nerve injury model
-----------------------------------------------------------------------------------------------

To study the process of axonal degeneration in vivo, we utilized the *Drosophila* wing nerve model ([@R22], [@R23]) and expressed the membrane-bound mCD8--GFP (green fluorescent protein) using a *dpr*-Gal4 driver to evaluate the integrity of the wing axons (fig. S1). Using this model, we performed a screen of existing RNA interference (RNAi) transgenic fly lines for genes required for the maintenance of the integrity and function of axons. We found three independent RNAi lines (nos. 105977, 35125, and 35126) of the same gene, *Vps4*, whose knockdown (KD) led to age-dependent axonal degeneration. The three lines showed similar effects, and two of them are shown in [Fig. 1 (A to C)](#F1){ref-type="fig"}. In addition, another gene found in the screen, *TSG101*, is a component of the ESCRT-I complex ([@R15]), and the RNAi-*TSG101* flies also caused age-dependent axonal degeneration (fig. S2, A and B), suggesting that the function of the ESCRT machinery was required for axonal integrity. To determine whether up-regulation of the two genes could provide axonal protection, we then generated the transgenic flies to overexpress them in the wing nerve. OE of *Vps4* ([Fig. 1, D to G](#F1){ref-type="fig"}) but not *TSG101* (fig. S2, C to E) was sufficient to suppress injury-induced axonal degeneration; we therefore focused mainly on investigating the axonal function of *Vps4* in this study.

![*Vps4* is required for axonal integrity and its OE delays WD.\
(**A** and **B**) Representative images of the wing axons labeled by mCD8-GFP of control (RNAi-Ctrl) or RNAi-*Vps4* flies at indicated ages. Axonal degeneration scores are evaluated as described in fig. S1 and quantified in (B). Data shown are means ± SEM; *n* = 7 to 10 wings per time point per genotype; \*\*\**P* \< 0.001; two-way analysis of variance (ANOVA). D3, day 3; D10, day 10; D20, day 20. (**C**) The KD efficiency of the RNAi-*Vps4* lines is analyzed by quantitative polymerase chain reaction (qPCR) and normalized to actin. Means ± SEM; *n* = 3; \*\*\**P* \< 0.001; Student's *t* test. (**D**) A schematic drawing of the *Drosophila* wing, highlighting the neuronal soma and axons in the costal, L1, and L3 wing veins. A pair of scissors indicates the injury site, which completely severed all axons of the L1 nerve, and the boxed area is imaged in (E). (**E** and **F**) Representative images (E) and quantification (F) of mCD8-GFP--labeled wing axons of the control (UAS-*luc*) or Vps4 OE flies (UAS-*Vps4*-V5) at indicated time points after axotomy. UAS, upstream activation sequence. Means ± SEM; *n* = 10 to 12 wings per time point per genotype; \*\*\**P* \< 0.001; two-way ANOVA. (**G**) Western blotting analysis confirming the expression Vps4-V5 in the transgenic flies. Scale bars, 20 μm (A) and 10 μm (E). GAPDH, glyceraldehyde-3-phosphate dehydrogenase.](aav4971-F1){#F1}

Changes in *Vps4* expression critically regulate autophagy levels in axons
--------------------------------------------------------------------------

Vps4 is a key protein component of the ESCRT machinery, which interacts with the ESCRT-III complex to mediate membrane scission in a variety of cellular processes including MVB biogenesis ([@R13], [@R15], [@R16]). Since the ESCRT machinery and MVBs play an important role in autophagic clearance, we asked whether the effect of *Vps4* KD and OE on axonal integrity and degeneration was due to a function of *Vps4* in regulating axonal autophagy. To test this hypothesis, we expressed mCherry-Atg8a in the wing nerve to assess the axonal autophagy levels. Atg8a is the *Drosophila* homolog of the microtubule-associated protein light chain 3 (LC3), a widely used autophagy marker whose puncta are indications of APs ([@R24]). The intact wing axons showed a very low basal level of autophagy, which was markedly increased as early as 3 hours after injury. The destruction of the injured axons began much later, as no significant axonal fragmentation was detected until 12 hours after axotomy (fig. S3).

*Vps4* KD in the wing nerve led to a significant increase of axonal mCherry-Atg8a puncta, which was evident at day 10 (D10) and became worse with age ([Fig. 2, A and B](#F2){ref-type="fig"}). The RNAi-*Vps4*--induced increase of axonal APs occurred much earlier than the breakdown of axonal integrity, which was not detected until D20 ([Fig. 1, A and B](#F1){ref-type="fig"}). *Vps4* OE substantially reduced the levels of injury-induced autophagy in the wing axons ([Fig. 2, C and D](#F2){ref-type="fig"}). Unlike *Vps4*, *TSG101* OE did not have the same regulatory impact on autophagy levels in axon injury (fig. S2, D and F), which might underlie the inability of *TSG101* OE to protect injured axons (fig. S2, D and E). Although OE of the known neuroprotector *Nmnat*, a key enzyme in the NAD^+^ biosynthesis pathway, delayed the breakdown of injured axons, it did not deter the injury-induced autophagy ([Fig. 2, E to G](#F2){ref-type="fig"}). These data suggest that the function of *Vps4* in regulating autophagy in axon injury was rather unique and that the increase in autophagy levels was not merely subsequent to injury-induced NAD^+^ depletion. Instead, the autophagy response and the regulation by *Vps4* might represent another important signal transduction pathway in axon injury and WD.

![Up-regulation of *Vps4* but not *Nmnat* alleviates the autophagy response in injured wing axons.\
(**A** to **D**) Representative images (A and C) and quantifications (B and D) of axonal APs labeled by mCherry-Atg8a in *Vps4* KD (A and B) or *Vps4* OE (C and D) flies at indicated time points during aging or after injury. RNAi-Ctrl, RNAi-*luc*; OE Ctrl, UAS-*luc*; and Vps4 OE, UAS-*Vps4*-V5. The average numbers of mCherry-Atg8a puncta per 50 μm of axons in (A) and (C) are quantified in (B) and (D), respectively. (**E** to **G**) Representative images (E) and quantifications (F and G) of mCD8-GFP--labeled wing axons and mCherry-Atg8a--labeled AP puncta in the control (UAS-*lacZ*) and Nmnat OE (UAS-*Nmnat*) flies. Means ± SEM; *n* = 7 to 12 wings per time point per group; \*\*\**P* \< 0.001; ns, not significant; two-way ANOVA. Scale bars, 20 μm (A), 10 μm (C), and 5 μm (E).](aav4971-F2){#F2}

To confirm that the observed mCherry-Atg8a puncta in the wing axons were indeed APs, we conducted RNAi KD of *Atg12* or *Atg17*, two core genes required for AP initiation and expansion, respectively. RNAi-*Atg12* or RNAi-*Atg17* almost completely blocked the formation of mCherry-Atg8a puncta, and the injury-induced autophagy was suppressed (fig. S4, A and B). Although, as previously reported ([@R25]), blocking the initiation of autophagy could delay injury-induced axonal degeneration to some extent (fig. S4, C and D), the protective effect was much weaker than that of *Vps4* OE: The axons of the *Vps4* OE flies were largely preserved even at 72 hours after injury ([Fig. 1, E and F](#F1){ref-type="fig"}), whereas the protection by RNAi-*Atg12* or RNAi-*Atg17* was only robust at 24 hours, and the axons were already much degenerated by 72 hours after injury (fig. S4, C and D). Thus, although both cause a significant reduction of injury-induced autophagy, the neuroprotection provided by *Vps4* OE was much more potent than simply blocking the formation of axonal APs, suggesting that the mechanism underlying the anti-degenerative function of *Vps4* was not merely to suppress the autophagy induction in axon injury.

*Vps4* promotes autophagic clearance in mammalian cells
-------------------------------------------------------

To understand how *Vps4* affected autophagy, we extended the study to mammalian systems. We used small interfering RNA (siRNA) to KD *Vps4B*/*SKD1* (the mammalian homolog of *Drosophila Vps4*) in mouse embryonic fibroblast (MEF) cells and assessed the autophagic flux in the cell using mTagRFP-mWasabi-LC3 ([Fig. 3A](#F3){ref-type="fig"}). The green but not the red fluorescence of mTagRFP-mWasabi-LC3 was bleached in the low pH when APs were fused with lysosomes to form autolysosomes (ALs). In the control cells transfected with scrambled siRNA, the LC3 signal appeared diffused with a few naturally occurring small LC3 puncta, which included both "red and green" APs and "red-only" ALs. In the si-*Vps4B* group, there was a notable accumulation of large LC3 puncta and aggregates, which were almost all red and green and lacked red-only ALs ([Fig. 3A](#F3){ref-type="fig"}). Moreover, the spectrum analysis showed a significant shift of the Pearson's correlation coefficient of mTagRFP and mWasabi in the si-*Vps4B* cells compared to the si-Ctrl group ([Fig. 3B](#F3){ref-type="fig"}), suggesting an impediment of autophagic flux due to *Vps4B* KD. The result was further supported by Western blotting analysis, as the autophagy markers LC3-II and P62 were accumulated in the cells transfected with si-*Vps4B* ([Fig. 3, C and D](#F3){ref-type="fig"}). Consistently, *Vps4B* OE significantly reduced LC3-II and P62 levels in MEF cells ([Fig. 3, E and F](#F3){ref-type="fig"}). In addition, lysosome blockade by chloroquine (CQ) abolished the influence of *Vps4B* KD or OE on autophagy levels ([Fig. 3, C to F](#F3){ref-type="fig"}). Together, the data indicated that *Vps4B* functioned by promoting autophagic flux but not autophagy induction.

![*Vps4* is essential and sufficient to promote autophagic flux.\
(**A**) Representative images of mTagRFP-mWasabi-LC3--labeled MEF cells to monitor autophagic flux. si-Ctrl, scrambled siRNA. Zoom-in insets: asterisk, AP; arrowhead, autolysosome. DAPI, 4′,6-diamidino-2-phenylindole. (**B**) The fluorescence intensity of mTagRFP and mWasabi of each pixel in (A) is measured and plotted. Pearson's correlation coefficient was used as a measure of colocalization of mTagRFP and mWasabi. The mean correlation coefficient value ± SEM of at least eight cells per group is shown; \*\**P* \< 0.01; Student's *t* test. (**C** to **F**) Western blot analysis of P62 and LC3-II in MEF cells with *Vps4B* KD (C) or *Vps4B* OE (E) in the absence or presence of CQ (10 μM). All protein levels are normalized to GAPDH, and the ratio in the control group without CQ is set to 1. The relative protein levels of P62 and LC3-II in (C) and (E) are quantified in (D) and (F), respectively. Means ± SEM; *n* = 3 to 4; \**P* \< 0.05, \*\**P* \< 0.01, and \*\*\**P* \< 0.001; ns, not significant; Student's *t* test. Scale bar, 5 μm.](aav4971-F3){#F3}

The neuroprotective function of *Vps4* is conserved in mammalian axons in vitro and in vivo
-------------------------------------------------------------------------------------------

We next wanted to determine whether the axonal function of *Vps4* is conserved in mammals. To test this hypothesis, we used the in vitro model of the primary mouse dorsal root ganglion (DRG) neurons. First, we characterized the localization of Vps4B protein in DRG neurons by immunocytochemistry: Vps4B was expressed in both soma and axons (fig. S5A). In addition to the ubiquitously distributed Vps4B signal in the DRG neurites, there were also periodic brighter Vps4B speckles. Vps4 is monomer or dimer in its inactive form in cytosol but assembles to dodecamer once it is recruited to the ESCRT-III complex ([@R26]). Thus, the Vps4B speckles along the axons are likely representative of endocytic vesicles where active Vps4B is recruited to the site of action ([@R27]).

We then generated lentivirus to overexpress *Vps4B* in mouse DRG neuron cultures (fig. S5, B and C). *Vps4B* OE significantly delayed the start of WD of injured DRG neurites: At 12 hours after injury, more than 83% of the DRG neurites in the control group (lenti-*Flag*) were fragmented, whereas the morphology of the injured DRG neurites in the *Vps4B* OE group (lenti-*Vps4B-Flag*) was well maintained and less than 12% of the axons showed degeneration ([Fig. 4, A and B](#F4){ref-type="fig"}). At 24 hours after injury when almost all control DRG neurites had degenerated, the *Vps4B* OE group just started to degenerate and less than 50% showed minor axonal fragmentation ([Fig. 4, A and B](#F4){ref-type="fig"}). Moreover, we found that *Vps4B* OE could further delay axonal degeneration in a *Sarm1* KD background ([Fig. 4, C to E](#F4){ref-type="fig"}). Loss of *Sarm1* was known to potently suppress injury-induced NAD^+^ decline and delay WD ([@R11]). Injured DRG neurites of the sh-Ctrl group showed remarkable axonal fragmentation at 12 hours after injury, which was delayed to 24 hours in the "sh-*Sarm1*" group and further delayed to 36 hours in the "sh-*Sarm1* + *Vps4B* OE" group. Note that, at the later time points, degenerated DRG neurites were detached from the culture dish and only floating axons or axonal debris were left for imaging. This was observed in all cases of the sh-Ctrl group and in more than half of the "sh-*Sarm1*" group but not in the "sh-*Sarm1* + *Vps4B* OE" group at 36 hours after injury ([Fig. 4C](#F4){ref-type="fig"}). Together with the finding that *Nmnat* OE did not suppress injury-induced autophagy ([Fig. 2, E to G](#F2){ref-type="fig"}), the data suggested that the "Vps4-autophagy" pathway might work independently and/or synergistically with the "Nmnat-Sarm1-NAD^+^" mechanism in triggering WD during axon injury.

![*Vps4B* OE delays axonal degeneration in the in vitro and in vivo mouse models.\
(**A** to **D**) Representative phase contrast images (A and C) and quantifications (B and D) of injured neurites of in vitro--cultured DRG neurons. Images are captured live at indicated time points after axotomy. Degenerated axons start to detach from the culture dish from 12 to 24 hours after injury, and in many cases, only floating axons or axonal debris are left at 36 hours. (**E**) *Sarm1* KD is achieved by lentiviral infection of short hairpin RNA (shRNA) and confirmed by Western blotting. *Vps4B* OE is examined and shown in fig. S5 (B and C). Ctrl, lenti-Flag; *Vps4B* OE, lenti-Vps4B-Flag; sh-Ctrl, scrambled shRNA; sh-*Sarm1*, shRNA of mouse *Sarm1*. Means ± SEM; *n* = 7 (A and B) and *n* = 5 to 8 (C and D) DRG cultures per group; \*\*\**P* \< 0.001; two-way ANOVA. (**F**) A schematic drawing of the mouse retinal ganglion cells (RGCs) and optic nerve injury model. (**G**) Representative images of GFP-positive optic axons from mice with adeno-associated virus (AAV)--hemagglutinin (HA) (control) or AAV-*Vps4B* injection at the indicated time after optic nerve crush. The mouse optic nerve was imaged distal to the crush site, at the point about 2 mm proximal to the optic chiasm. Injured axons show swelling, beading, and fragmentation. dpc, days postcrush. (**H**) Quantification from (G). Means ± SEM; *n* = 5 mice per group; \**P* \< 0.05; two-way ANOVA. Scale bars, 50 μm (A and C) and 100 μm (G).](aav4971-F4){#F4}

Furthermore, to validate the axonal protective effect of *Vps4B* in an in vivo mammalian system, we generated adeno-associated virus (AAV) to overexpress *Vps4B* in mouse neurons. The AAV-Vps4B was injected into the mouse retinal ganglion cells (RGCs), and the optic nerve was then injured by a crush ([Fig. 4F](#F4){ref-type="fig"}). Degeneration of the crushed mouse optic nerve was evident at 3 days postcrush (dpc), displaying remarkable axonal swelling, beading, and fragmentation ([Fig. 4G](#F4){ref-type="fig"}). *Vps4B* OE markedly delayed the start of the optic nerve degeneration from 3 to 6 dpc ([Fig. 4G](#F4){ref-type="fig"}), as there was a significant reduction of fragmented optic axons in the AAV-*Vps4B* group compared to the AAV-HA control group at 3 dpc ([Fig. 4H](#F4){ref-type="fig"}). Together, in both in vitro and in vivo mouse models as well as in the *Drosophila* nervous system, up-regulation of *Vps4* significantly delayed WD of injured axons.

The Vps4B protein is rapidly depleted in mouse DRG axons after injury
---------------------------------------------------------------------

To investigate how Vps4B responds to axon injury and whether the response underlies its axonal function in WD, we vigorously examined Vps4B levels before and after injury in mouse DRG neurites. We found that Vps4B protein was rapidly depleted from injured DRG axons---the decrease was evident as early as 2 hours and became more robust at 4 hours, at which the Vps4B signals showed a "beading" appearance ([Fig. 5A](#F5){ref-type="fig"}). This was likely reminiscent of the periodic brighter Vps4B dots in intact axons (fig. S5A). By 6 hours after injury, Vps4B signals were largely undetectable ([Fig. 5, A and C](#F5){ref-type="fig"}). The integrity of axonal cytoskeleton of the DRG neurites (Tuj 1 staining) did not show significant fragmentation until 6 to 8 hours after injury ([Fig. 5, A and C](#F5){ref-type="fig"}). In contrast, a remarkable increase of LC3 puncta began at \~4 hours after axotomy ([Fig. 5, B and C](#F5){ref-type="fig"}), which was subsequent to Vps4B reduction but before the start of axonal degeneration ([Fig. 5, A and C](#F5){ref-type="fig"}). Moreover, Western blotting analysis of the protein extracts from the severed DRG neurites confirmed that Vps4B protein levels decreased abruptly at 2 hours, whereas the autophagy marker LC3-II started to increase from 2 hours, continued to accumulate, and was maintained at high levels throughout all time points tested in this study ([Fig. 5, D and E](#F5){ref-type="fig"}).

![The impact of injury on Vps4 protein and autophagy levels in mouse DRG neurites.\
(**A** to **C**) Representative confocal images of mouse DRG explants immunostained for β-tubulin III (Tuj 1) and Vps4B in (A) or LC3 in (B) at the indicated time after injury. The relative intensity of Vps4B fluorescence and the percentage of degenerated axons (Tuj 1) in (A) and the average number of LC3 puncta per 25 μm of axons in (B) are quantified in (C). (**D** and **E**) The representative Western blot (D) and quantification analysis (E) of Vps4B and LC3-II protein levels in injured DRG neurites at indicated time points. All proteins are normalized to β-actin and shown as relative levels to that of the uninjured axons (0 hours). Means ± SEM; *n* = 8 (A), *n* = 10 (B), and *n* = 3 (D) per group; \**P* \< 0.05, \*\**P* \< 0.01, and \*\*\**P* \< 0.001; Student's *t* test, compared to the level at 0 hours (sham control). Scale bars, 100 μm (A) and 5 μm (B).](aav4971-F5){#F5}

DISCUSSION
==========

The temporal relationship of Vps4B decrease, autophagy increase, and axonal degeneration, together with the findings that down-regulation of *Vps4* leads to AP accumulation and axon self-destruction whereas up-regulation of *Vps4* improves autophagic flux and suppresses WD, implicates that the rapid depletion of Vps4 protein may trigger injury-induced autophagy and axonal degeneration. In addition, the injury-induced depletion may make Vps4B the "bottleneck step" of the ESCRT machinery in the endocytic/autophagic pathway, which might explain why up-regulation of only *Vps4* but not of the other ESCRT components such as *TSG101* is sufficient to reduce AP accumulation and delay degeneration of injured axons.

Functions of ESCRT in neuronal axons have been largely neglected, and major gaps exist in current knowledge. In this study, we identify ESCRT-Vps4 as a novel anti-degenerative molecule in axon injury. We show that rapid Vps4 depletion impairs autophagic flux in axons that contributes considerably to injury-induced autophagy, which adds substantially to the previous view that autophagy in injury was primarily an "activation" of AP biogenesis ([@R25]). Both insufficient and excessive autophagy can lead to axonal degeneration. Our current data indicate that the accumulation of APs per se is likely "toxic" and may serve as a signal to trigger the self-destruction process in injured axons.

The "ESCRT-Vps4-autophagy" is likely one of the wide array of signal transduction pathways that are activated upon axon injury. For example, since the ESCRT machinery is required for membrane protein sorting and turnover ([@R15]), the consequence of Vps4 depletion may also involve alteration of membrane receptor signaling pathways. We show that *Nmnat* OE does not suppress injury-induced autophagy, whereas *Vps4B* OE shows an additive effect to *Sarm1* KD in protecting injured axons. Thus, "ESCRT-Vps4-autophagy" may represent a novel and important signaling pathway that functions in parallel to the Nmnat/Sarm1-NAD^+^ mechanism in initiating WD ([Fig. 6](#F6){ref-type="fig"}). Future studies are needed to understand how Vps4 protein is down-regulated in injury and to develop intervention strategies against axonal degeneration in neural injury and diseases via modulating ESCRT activity.

![A working model of Vps4 in axon injury and WD.\
Injury induces rapid depletion of Vps4, which impairs autophagic flux and causes massive AP accumulation, which can lead to axonal degeneration. Meanwhile, Sarm1 is activated and Nmnat2 is degraded upon injury, which cause the NAD^+^ depletion that can also trigger axonal degeneration. Since *Nmnat* OE does not suppress injury-induced autophagy, whereas *Vps4* OE can further delay WD in the *Sarm1* KD background, the two mechanisms likely function independently to transduce the injury signal and synergistically promote the initiation of WD. "??", unknown or additional downstream targets.](aav4971-F6){#F6}

MATERIALS AND METHODS
=====================

Statement of animal care and surgical procedures
------------------------------------------------

All surgical procedures in mice were performed in compliance with the institutional guidelines on the scientific use of living animals at the Interdisciplinary Research Center on Biology and Chemistry, Chinese Academy of Sciences (CAS), or with the protocols approved by the Animal and Plant Care Facility at the Hong Kong University of Science and Technology. In this study, "Principles of Laboratory Animal Care" \[National Institutes of Health (NIH) publication no. 86-23, revised 1985\] were followed. Animal distress and conditions requiring euthanasia were addressed, and the number of animals used was minimized.

*Drosophila* stocks
-------------------

The UAS-Dcr2 (24651), UAS-RNAi-*luciferase* (31603), UAS-RNAi-*mCherry* (35785), UAS-RNAi-*Atg12* (34675), and UAS-RNAi-*Atg17* (36918) flies were from the Bloomington *Drosophila* Stock Center (BDSC); the three UAS-RNAi-*Vps4* lines (nos. 105977, 35125, and 35126) were from the Vienna *Drosophila* Resource Center (VDRC); and the UAS-RNAi-*TSG101* (9712R-1) flies were from the Fly Stocks of National Institute of Genetics (NIG-FLY). The UAS-*mCherry-Atg8a* fly line was previously described ([@R28]). For neuronal expression of long hairpin RNAi lines, RNAi-*luciferase* was used as a control and a copy of UAS-Dcr2 was coexpressed to boost the KD efficiency ([@R29]); for V20 RNAi lines that express short hairpin RNA (shRNA), no additional UAS-Dcr2 was needed and RNAi-*mCherry* was used as a control.

For in vivo imaging of axon membrane and axonal APs or to simultaneously manipulate gene expression, the following stable fly lines carrying multiple transgenes were generated by chromosomal recombination:

yw;dpr-Gal4,UAS-mCD8-GFP,UAS-mCherry-Atg8a/CyO

yw;dpr-Gal4,UAS-mCD8-GFP,UAS-mCherry-Atg8a/CyO;UAS-Dcr2/TM3.Ser

yw;d*pr-Gal4,UAS-GAL4,UAS-mCD8-CherryRFP/CyO;UAS-Dcr2/TM3.Ser*

All flies tested in this study were raised on standard cornmeal media and maintained at 25°C and 60% relative humidity.

Generation of transgenic fly strains
------------------------------------

To generate pBID-UASC-Vps4-V5 and pBID-UASC-TSG101-V5 plasmids, DNA fragments encoding *Drosophila Vps4* and *TSG101* were amplified from complementary DNA (cDNA) \[the Drosophila Genomics Resource Center (DGRC), GH02678, and RE26756, respectively\], subcloned into pIZ-V5-6xHis vector using the Eco RI/Sac II sites, and then subcloned with a V5 tag into the pBID-UASC vector ([@R30]) using the Eco RI/Eag I sites. The polymerase chain reaction (PCR) primers used are listed below:

*Vps4* F1: 5′-CCGAATTCTAAATCACCATGGCAGCCG-3′

*Vps4* R1: 5′-TTCCGCGGGCCCTCCTGCCCAAAGTC-3′

*Vps4* F2: 5′-CCGAATTCTAAATCACCATGGCAGCCG-3′

*Vps4* R2: 5′-GACGGCCGCTCAATGGTGATGGTGATGATG-3′

*TSG101* F1: 5′-CCGAATTCAGCACAATGCCTGCGGTT-3′

*TSG101* R1: 5′-TTCCGCGGTGCTTTGATGTGCTCCTCG-3′

*TSG101* F2: 5′-CCGAATTCAGCACAATGCCTGCGGTT-3′

*TSG101* R2: 5′-GACGGCCGCTCAATGGTGATGGTGATGATG-3′

The transgenic fly strains of UAS-Vps4-V5 and UAS-TSG101-V5 were generated by ΦC31 integrase-mediated, site-specific integration into the fly genome, which allowed uniform transgene expression across different lines. The attP landing site stock used in this study was UAS-phi2b2a;VK5 (75B1) and a transgenic pBID-UASC-*luciferase* fly strain generated using the same method, and the same landing site ([@R31]) was used as a control.

*Drosophila* wing nerve injury and imaging procedure
----------------------------------------------------

The *Drosophila* wing nerve was injured and visualized as previously described ([@R22], [@R23]). Briefly, to sever the wing axons, flies were anesthetized using CO~2~ gas and the wings were cut using handheld spring scissors (Fine Science Tools, 15000-08). The integrity and autophagy levels of the wing axons were indicated by mCD8-GFP and mCherry-Atg8a, respectively. For confocal images, wings were detached from fly bodies, briefly washed with PBST (0.2% Triton X-100/PBS), and then mounted directly in VECTASHIELD Mounting Medium (Vector Laboratories, H-1000). Images were taken with a Leica TCS SP8 confocal microscope using a 63× oil objective \[numerical aperture (NA) = 1.4\]. Images were processed and analyzed in LAS X and ImageJ software and assembled into figures using Photoshop CS6 (Adobe Systems Inc.) with similar settings. The axonal degeneration score and the number of axonal APs were quantified as described in fig. S1.

RNA extraction and real-time quantitative PCR
---------------------------------------------

For quantitative PCR (qPCR), total RNA was isolated from the heads of 5-day-old adult flies using TRIzol (Invitrogen). Approximately 30 to 35 fly heads were collected for each repeat, and three biological repeats were performed for the statistical analysis. Deoxyribonuclease (Promega) was applied to remove genomic DNA. Reverse transcription (RT) reactions were then performed using the High-Capacity cDNA Reverse Transcription kit with random primers (Applied Biosystems). The cDNA was then used for qPCR with SYBR Select Master Mix (Applied Biosystems) via the QuantStudio 6 Flex Real-Time PCR System (Life Technologies). *Actin* was used as an internal reference. The following related fly qPCR primers were used:

*actin* F: 5′-GAGCGCGGTTACTCTTTCAC-3′

*actin* R: 5′-GCCATCTCCTGCTCAAAGTC-3′

*Atg12* F: 5′-GAGCACTTCCTCCTCCACAC-3′

*Atg12* R: 5′-CTACGGTCCAGGTTCGCTTT-3′

*Atg17* F: 5′-CACCCAAGAGACATACCAGC-3′

*Atg17* R: 5′-AGATCGTAGGCAGAGCTTCT-3′

*Vps4* F: 5′-ACTGCGTCTGTATGAGCACG-3′

*Vps4* R: 5′-CTCCTTTAGCTTCTCGGCCC-3′

Plasmids and constructs
-----------------------

To generate the pCMV-Vps4B-3xFlag plasmid, the human Vps4B cDNA was amplified from human umbilical vein endothelial cells by RT-PCR and inserted into the pCMV-3Tag-3B expression vector (SnapGene) between Bam HI and Hind III sites using the ClonExpress MultiS One Step Cloning Kit (Vazyme). The PCR primers used are listed below:

*Vps4B* F1: 5′-GAGCGCGGTTACTCTTTCAC-3′

*Vps4B* R1: 5′-GCCATCTCCTGCTCAAAGTC-3′

*Vps4B* F2: 5′-CGCTCTAGCCCGGGCGGATCCGCCACCATGTCATCCACTTCGCCCAA-3′

*Vps4B* R2: 5′-GTCGACGGTATCGATAAGTCCTTGCCTTCTTGACCAAAATCTTCTG-3′

All constructs were verified by sequencing to ensure the integrity of the cloned open reading frames. The pcDNA3.1-mTagRFP-mWasabi-LC3 plasmid was previously described ([@R32]). The *Vps4B* siRNA oligo was GAUGGAUGUUCCUGGAGAUTT (GenePharma).

Cell cultures and transfection
------------------------------

Mouse MEF cells were cultured in Dulbecco's modified Eagle's medium (Gibco) with 10% (v/v) fetal bovine serum (Gibco) and 1% penicillin/streptomycin at 37°C in 5% CO~2~. Transient transfection was performed using Lipofectamine 3000 (Invitrogen) for DNA and Lipofectamine RNAiMAX (Invitrogen) for siRNA in reduced serum Opti-MEM medium (Gibco) according to the manufacturer's protocol. For lysosome blockade experiments, MEF cells were treated with 10 μM CQ (Sigma) for 8 hours before harvest.

Lentiviral vectors and infection
--------------------------------

To generate the pLenti-hSyn-*Vps4B-Flag* plasmid, DNA fragments were amplified from pCMV-*Vps4B*-3xFlag by PCR and subcloned into a pLenti-hSyn vector ([@R33]) for neuron-specific expression using the Bam HI/Eco RI sites by homologous recombination as above. The PCR primers are listed below:

Lenti-*Vps4B* F1: 5′-GCCACCATGTCATCCACTTC-3′

Lenti-*Vps4B* R1: 5′-CCGGGCCCTATTTATCGT-3′

Lenti-*Vps4B* F2: 5′-AGAGCGCAGTCGAGAGGATCCGCCACCATGTCATCCACTTC-3′

Lenti-*Vps4B* R2: 5′-GATAAGCTTGATATCGAATTCCCGGGCCCTATTTATCGT-3′

To generate the pLKO-shRNA-Sarm1 plasmid, the shRNA of the mouse Sarm1 was cloned into the pLKO.1 vector. The oligo primers used were as follows: sh-*Sarm1* F, 5′-CCGGCCACATTATCAGAGAGCCAAACTGCAGTTTGGCTCTCTGATAATGTGGTTTTTG-3′; sh-*Sarm1* R, 5′-AATTCAAAAACCACATTATCAGAGAGCCAAACTGCAGTTTGGCTCTCTGATAATGTGG-3′. The negative control vector containing scrambled shRNA was obtained from Addgene (no. 1864), and the sequence of the hairpin was CCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGG.

Lentivirus to express *Vps4B-Flag* or sh-*Sarm1* was prepared according to the established protocols. Briefly, 293T cells were cotransfected with pLenti-hSyn-*Vps4B-Flag* or pLKO.1-sh-*Sarm1*, vesicular stomatitis virus glycoprotein, and delta 8.9 with a ratio of 1:1.5:2 in Opti-MEM I medium using PolyJet reagent (SignaGen). Lenti-hSyn-Flag was packaged similarly and used as a control. Culture supernatant was collected at 48 hours after transfection and passed through a 0.45-μm filter. Fresh medium containing viral particles was used or stored at 4°C for less than 1 week before DRG culture infection.

DRG neuron culture, in vitro axotomy, and quantification
--------------------------------------------------------

Dissection of C57BL/6 mouse embryonic DRG was carried out as previously described ([@R34]). For DRG explants, individual DRGs were seeded in the middle of the insert of the Transwell culture system (Corning, 35302) as described before ([@R35]). On 7 days in vitro (DIV), axotomy was performed by scraping the upper side of the insert that contained the cell bodies of the DRG explants using a cell scraper. To culture dissociated DRG neurons (for Vps4B viral infection), dissected DRGs were digested with collagenase and TrypLE Express Enzyme (Gibco) and the suspended DRG neurons were placed as a drop (5 to 10 μl) in the center of each well for 15 to 20 min. After cells were attached, 1 ml of culture medium was gently added to each well of a 12-well plate. The DRG neurons were then infected with pLenti-hSyn-*Vps4B*-*Flag* on 7 DIV, and axotomy was performed under the microscope using a micro surgical blade (WHB, C21) on 14 DIV.

Bright-field images of in vitro--cultured DRG neurites were taken live at indicated time points after axotomy using a Leica DMi8 inverted microscope. The severity of neurite degeneration was quantified as previously described ([@R36]). Briefly, the degeneration index was calculated as the ratio of the degenerated neurite pixel number to the total neurite pixel number. Numbers of random, nonoverlapping images of different DRG explants of each group from pooled results of at least three independent repeats are indicated in each figure.

AAV injection and mouse optic nerve injury
------------------------------------------

We used AAV serotype 2/2 to overexpress Vps4B, GFP, and 2×HA tag. RGCs of B6 mice were transduced with AAV-GFP virus to do sparse labeling and with AAV2-hSynapsin-2×HA or AAV2-hSynapsin-VPS4B virus to achieve saturated infection. Specifically, 2 μl of AAV2-hSynapsin-GFP virus with a titer of \~10^8^ GC/ml was injected into the vitreous bodies of 5- to 6-week-old B6 mice to achieve RGCs sparse labeling. Four weeks later, mice were injected with AAV2-hSyanpsin-2×HA (control) or AAV2-hSynapsin-Vps4B with a titer of about 10^13^ GC/ml. After 4 weeks, optic nerve crush was performed with jeweler's forceps (Dumont \#5; Fine Science Tools) for 2 s at the point about 1 mm behind the optic disk. The mice were kept alive for 3 or 6 days before they were euthanized for imaging analysis of the optic nerve.

Imaging and quantification of axonal degeneration in mouse optic nerve
----------------------------------------------------------------------

GFP-labeled mouse optic nerve was imaged by confocal microscopy at the point about 2 mm proximal to the optic chiasm. For quantification, around 100 GFP-positive RGC axons of each nerve sample were examined. The axons with fragmentation or breaks were scored as degenerated. Degeneration index was quantified as the percentage of all axons scored as degenerated. Five mice were included in each group.

Antibodies
----------

The following primary antibodies were used for Western blotting and immunostaining in this study: mouse anti-Flag (Sigma-Aldrich, F3165), rabbit anti-Flag (Proteintech, 20543-1-AP), rabbit anti-Vps4B (Proteintech, 17673-1-AP), mouse anti-P62 (Abcam, ab56416), rabbit anti-LC3B (Abcam, ab48394), mouse anti-V5 (Proteintech, 66007-1-Ig), mouse anti--glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Proteintech, 60004-1-Ig), mouse anti--β-tubulin class III (Tuj 1; Abcam, ab78078), rabbit anti--Tuj 1 (Sigma-Aldrich, T2200), and mouse anti--β-actin (Cell Signaling Technology, 3700). The horseradish peroxidase--conjugated secondary antibodies were as follows: goat anti-mouse (Sigma-Aldrich, A4416) and goat anti-rabbit (Sigma-Aldrich, A9169). The fluorophore-conjugated secondary antibodies were as follows: goat anti-rabbit Alexa Fluor 488 (Life Technologies, A11036), goat anti-mouse Alexa Fluor 488 (Life Technologies, A11029), goat anti-mouse Alexa Fluor 568 (Life Technologies, A11031), goat anti-rabbit Cy5 (Life Technologies, A10523), and goat anti-mouse Cy5 (Life Technologies, A105234).

Immunocytochemistry
-------------------

MEF cells were grown on chamber slides (Lab-Tek) and transfected with the indicated plasmids for 48 hours. Cells were fixed with fresh paraformaldehyde (Sangon, A500684) in PBS for 15 min at room temperature, permeabilized with 0.5% Triton X-100 (Sigma-Aldrich, T8787) in PBS for 15 min, and then blocked with 3% goat serum in PBST (1× PBS + 0.1% Triton X-100) for 60 min at room temperature. Cells were then incubated with the indicated antibodies in blocking buffer at 4°C overnight, followed by incubation of appropriate secondary antibodies at room temperature for 1.5 to 2 hours. The chamber slides were then disassembled according to the manufacturer's instruction and mounted in VECTASHIELD Mounting Medium with 4′,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, H-1200) with cover glass. For DRG neurites, immunostaining was performed similarly except that the filters of the Transwell inserts were taken off, processed, and mounted on a glass slide in VECTASHIELD Mounting Medium (Vector Laboratories, H-1000) with coverslip for confocal imaging.

Protein extraction and Western blotting
---------------------------------------

Cells were lysed in the cell extraction buffer (Invitrogen, FNN0011) with the protease inhibitor cocktail (Roche), sonicated on ice, and then centrifuged at 13,000*g* for 20 min at 4°C. Equivalent amounts of lysates were resolved by electrophoresis through a 12% bis-tris SDS--polyacrylamide gel electrophoresis gel (Invitrogen) and probed with the primary and secondary antibodies listed above. Detection was performed using the High-sig ECL Western Blotting Substrate (Tanon). Images were captured using an Amersham Imager 600, and densitometry was measured using the ImageQuant TL software (GE Healthcare) and ImageJ (NIH).

Statistical analysis
--------------------

Statistical significance in this study was determined by two-way analysis of variance (ANOVA) with Bonferroni's post hoc test or unpaired, two-tailed Student's *t* test at \**P* \< 0.05, \*\**P* \< 0.01, and \*\*\**P* \< 0.001, as indicated in the figures. Error bars represent SEM.
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Fig. S1. The evaluation system of wing axonal degeneration scores.

Fig. S2. The ESCRT-I component TSG101 is required but not sufficient to maintain axonal integrity.

Fig. S3. Axon injury induces a rapid autophagy response followed by axonal destruction.

Fig. S4. Inhibition of autophagy induction by RNAi-*Atg12* or RNAi-*Atg17* provides moderate axonal protection.

Fig. S5. Examination of endogenous Vps4B protein and lentiviral OE of Vps4B in mouse DRG neurons.
